Molecular Basis of Bioelectronic Medicine
生物电子医学的分子基础
基本信息
- 批准号:9071799
- 负责人:
- 金额:$ 51.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-01 至 2021-04-30
- 项目状态:已结题
- 来源:
- 关键词:Anti-Inflammatory AgentsAnti-inflammatoryAutoimmune DiseasesBiologyCytokine GeneDataDevicesDiseaseElectronicsEtiologyFundingFutureGene ExpressionImmune responseInfectionInflammationInflammation MediatorsInflammatoryInjuryLaboratoriesMapsMediatingMedicineModalityMolecularMolecular TargetNational Institute of General Medical SciencesNeurotransmittersPreventionReflex actionRegulationReperfusion InjuryResearch PersonnelResearch SupportSepsisShockSterilityTherapeuticWorkbasecytokineneural circuitpublic health relevancetherapy development
项目摘要
DESCRIPTION (provided by applicant): Inflammation, mediated by the immune response to infection and sterile injury, is a major underlying cause of disease. Advances in understanding the molecular mechanisms of inflammation hold promise for developing future therapies for severe sepsis, shock, ischemia reperfusion injury, autoimmune diseases, and other debilitating diseases of national importance. Research supported by the NIGMS in the principle investigator's lab has revealed mechanisms to control inflammation by identifying and targeting specific cytokines, and by mapping and targeting specific neural circuits that control their activity. This work has now progressed to launching a new field, termed "bioelectronic medicine," which holds promise as strategy to develop therapies using electronic devices to target anti-inflammatory neural circuits. The present proposal seeks to understand unanswered questions about the molecular mechanisms controlling inflammation as derived from three existing RO1 funded projects in the PI's laboratory. The first is to understand the identity and mechanisms of the reflex neural circuits that control immune responses. The second is to understand the biology of cytokine mediators of inflammation that are necessary and sufficient for disease causation. And the third is to understand the molecular mechanisms that regulate cytokine release under the influence of neurotransmitters, including regulation of cytokine gene expression and inflammasome activity. The successful completion of this work will provide significant new data necessary to develop therapeutic modalities for the prevention and treatment of inflammation using bioelectronic devices.
描述(由申请人提供):由对感染和无菌损伤的免疫反应介导的炎症是疾病的主要根本原因。了解炎症分子机制的进展有望开发未来治疗严重败血症、休克、缺血再灌注损伤、自身免疫性疾病和其他国家重要衰弱性疾病的疗法。由首席研究员实验室的 NIGMS 支持的研究揭示了通过识别和针对特定细胞因子以及通过绘制和针对控制其活动的特定神经回路来控制炎症的机制。这项工作现已进展到推出一个名为“生物电子医学”的新领域,该领域有望作为开发使用电子设备针对抗炎神经回路的疗法的策略。本提案旨在了解有关控制炎症的分子机制的未解答问题,这些问题源自 PI 实验室现有的三个 RO1 资助的项目。首先是了解控制免疫反应的反射神经回路的身份和机制。第二个是了解炎症细胞因子介质的生物学,这对于疾病的致病是必要且充分的。第三是了解神经递质影响下调节细胞因子释放的分子机制,包括细胞因子基因表达和炎症小体活性的调节。这项工作的成功完成将为开发使用生物电子设备预防和治疗炎症的治疗方式提供必要的重要新数据。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kevin J Tracey其他文献
Regulating innate immunity with dopamine and electroacupuncture
用多巴胺和电针调节先天免疫
- DOI:
10.1038/nm.3501 - 发表时间:
2014-03-04 - 期刊:
- 影响因子:50.000
- 作者:
Sangeeta S Chavan;Kevin J Tracey - 通讯作者:
Kevin J Tracey
Neural regulation of immunity: molecular mechanisms and clinical translation
免疫的神经调节:分子机制与临床转化
- DOI:
10.1038/nn.4477 - 发表时间:
2017-01-16 - 期刊:
- 影响因子:20.000
- 作者:
Valentin A Pavlov;Kevin J Tracey - 通讯作者:
Kevin J Tracey
It takes nerve to dampen inflammation
抑制炎症需要勇气。
- DOI:
10.1038/ni0805-756 - 发表时间:
2005-08-01 - 期刊:
- 影响因子:27.600
- 作者:
Christine N Metz;Kevin J Tracey - 通讯作者:
Kevin J Tracey
From mouse to man: or what have we learned about cytokine-based anti-inflammatory therapies?
从小鼠到人类:或者我们对基于细胞因子的抗炎疗法了解了什么?
- DOI:
- 发表时间:
1999 - 期刊:
- 影响因子:3.1
- 作者:
Kevin J Tracey;Edward Abraham - 通讯作者:
Edward Abraham
Tumor necrosis factor in the malnutrition (cachexia) of infection and cancer.
感染和癌症营养不良(恶病质)中的肿瘤坏死因子。
- DOI:
- 发表时间:
1992 - 期刊:
- 影响因子:3.3
- 作者:
Kevin J Tracey;A. Cerami - 通讯作者:
A. Cerami
Kevin J Tracey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kevin J Tracey', 18)}}的其他基金
PKR mediated inflammasome activation and pyroptosis in sepsis
脓毒症中 PKR 介导的炎症小体激活和细胞焦亡
- 批准号:
8496322 - 财政年份:2014
- 资助金额:
$ 51.42万 - 项目类别:
Macrophage Inactivation in Sepsis after Shock or Trauma
休克或创伤后脓毒症中巨噬细胞失活
- 批准号:
7933295 - 财政年份:2009
- 资助金额:
$ 51.42万 - 项目类别:
VAGUS NERVE STIMULATION IN RHEUMATOID ARTHRITIS (VANSRA)
迷走神经刺激治疗类风湿性关节炎 (VANSRA)
- 批准号:
7951920 - 财政年份:2009
- 资助金额:
$ 51.42万 - 项目类别:
CHOLINERGIC MODULATION OF CYTOKINE SYNTHESIS IN SEPSIS SURVIVORS
脓毒症幸存者细胞因子合成的胆碱能调节
- 批准号:
7719247 - 财政年份:2008
- 资助金额:
$ 51.42万 - 项目类别:
相似海外基金
Development of Enhanced Anti-inflammatory Blood Mononuclear Cell Therapy for ARDS and Elucidation of the Molecular Mechanism
ARDS增强抗炎血液单核细胞治疗的进展及分子机制的阐明
- 批准号:
23K07659 - 财政年份:2023
- 资助金额:
$ 51.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Exploring therapeutic effects of anti-inflammatory and resolving factors in osteoporosis model mice
探讨抗炎和缓解因子对骨质疏松模型小鼠的治疗作用
- 批准号:
23K15705 - 财政年份:2023
- 资助金额:
$ 51.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Investigation of the relation between age-related estradiol fluctuation and pro-/anti-inflammatory effects in transplant immune response.
研究年龄相关雌二醇波动与移植免疫反应中促/抗炎作用之间的关系。
- 批准号:
23K19490 - 财政年份:2023
- 资助金额:
$ 51.42万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Non-coating anti-microbial, anti-host protein deposition, anti-inflammatory urinary catheter
无涂层抗菌、抗宿主蛋白沉积、抗炎导尿管
- 批准号:
10697567 - 财政年份:2023
- 资助金额:
$ 51.42万 - 项目类别:
Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus
维拉帕米作为新型神经保护和抗炎剂的鉴定和优化,用于减少有机磷引起的癫痫持续状态后的长期神经系统发病率
- 批准号:
10727765 - 财政年份:2023
- 资助金额:
$ 51.42万 - 项目类别:
Anti-inflammatory Effects of Hydrogen Gas Produced by Gut Microflora in a Mouse Model of ARDS
肠道菌群产生的氢气对 ARDS 小鼠模型的抗炎作用
- 批准号:
23K08467 - 财政年份:2023
- 资助金额:
$ 51.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Knockdown of AdipoR2 Compromises Adiponectin’s Anti-inflammatory Actions by Mainly Promoting a Pro-inflammatory Chemokine and Cytokine Secretory Profile in THP-1 Macrophages
AdipoR2 的敲低主要通过促进 THP-1 巨噬细胞中促炎趋化因子和细胞因子的分泌特征来损害脂联素的抗炎作用
- 批准号:
493138 - 财政年份:2023
- 资助金额:
$ 51.42万 - 项目类别:
Elucidation of anti-inflammatory mechanism of surface layer protein of lactic acid bacteria focusing on its interaction with lipopolysaccharide.
阐明乳酸菌表面层蛋白的抗炎机制,重点关注其与脂多糖的相互作用。
- 批准号:
23K13905 - 财政年份:2023
- 资助金额:
$ 51.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
SBIR Phase I: Structure-guided design of anti-inflammatory modulators of protease-activated receptor 1 (PAR1)
SBIR I 期:蛋白酶激活受体 1 (PAR1) 抗炎调节剂的结构引导设计
- 批准号:
2223225 - 财政年份:2023
- 资助金额:
$ 51.42万 - 项目类别:
Standard Grant
Targeting anti-viral and anti-inflammatory responses during ocular HSV-1 infection to prevent vision impairment.
针对眼部 HSV-1 感染期间的抗病毒和抗炎反应,以预防视力障碍。
- 批准号:
10651054 - 财政年份:2023
- 资助金额:
$ 51.42万 - 项目类别:














{{item.name}}会员




